![Megan Filoon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Megan Filoon
Compliance Officer chez
ELICIO THERAPEUTICS, INC.
Profil
Ms. Megan Filoon is a Secretary, Compliance Officer & General Counsel at Elicio Therapeutics, Inc. Ms. Filoon was previously employed as a Secretary & General Counsel by Molecular Templates, Inc. and a Corporate Associate by Blank Rome LLP.
She received her undergraduate degree from Boston University and a graduate degree from Rutgers Law School.
Postes actifs de Megan Filoon
| Sociétés | Poste | Début |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Compliance Officer | 28/08/2023 |
Anciens postes connus de Megan Filoon
| Sociétés | Poste | Fin |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Conseiller Juridique Général | 01/08/2023 |
Blank Rome LLP
 Blank Rome LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2018 |
Formation de Megan Filoon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blank Rome LLP
Blank Rome LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Rutgers Law School
 Rutgers Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Elicio Therapeutics, Inc.
 Elicio Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapies | Health Technology |
